TY - JOUR
T1 - Centralization and prospective audit of cystectomy are necessary
T2 - a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database
AU - Viswambaram, Pravin
AU - McCombie, Steve P.
AU - Hawks, Cynthia
AU - Wallace, D. Michael A.
AU - Sengupta, Shomik
AU - Hayne, Dickon
PY - 2023/6
Y1 - 2023/6
N2 - Bladder cancer (BC) outcomes are unacceptably poor. In Australia, BC survival is actually deteriorating. There is an urgent need to improve outcomes in BC patients, which requires a multipronged approach. One area deserving closer scrutiny is radical cystectomy. Audit is necessary to identify areas for improvement and without it, outcomes remain unknown. Evidence convincingly shows high-volume surgeons and centers improve cystectomy outcomes including overall survival, yet centralization has still not occurred. The Australia and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group cystectomy database has been established to facilitate cystectomy audit in Australia and New Zealand. We present initial data from the ANZUP cystectomy database from a single high-volume center, discuss the benefits of centralization and its challenges in the Asia-Pacific context.
AB - Bladder cancer (BC) outcomes are unacceptably poor. In Australia, BC survival is actually deteriorating. There is an urgent need to improve outcomes in BC patients, which requires a multipronged approach. One area deserving closer scrutiny is radical cystectomy. Audit is necessary to identify areas for improvement and without it, outcomes remain unknown. Evidence convincingly shows high-volume surgeons and centers improve cystectomy outcomes including overall survival, yet centralization has still not occurred. The Australia and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group cystectomy database has been established to facilitate cystectomy audit in Australia and New Zealand. We present initial data from the ANZUP cystectomy database from a single high-volume center, discuss the benefits of centralization and its challenges in the Asia-Pacific context.
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000880473700001
U2 - 10.1111/ajco.13883
DO - 10.1111/ajco.13883
M3 - Review article
C2 - 36352543
SN - 1743-7555
VL - 19
SP - 290
EP - 295
JO - Asia-Pacific Journal of Clinical Oncology
JF - Asia-Pacific Journal of Clinical Oncology
IS - 3
ER -
